Danaher Corporation (DHR)
NYSE·Healthcare·Medical - Diagnostics & Research
$232.40
—
Mkt Cap $163.77B
Analyst Ratings
Buy
17
Hold
3
Sell
0
Price Target (59 analysts)
$223.77
Range $195.00 – $250.00
Implied Upside
-3.7%
Consensus $223.77 vs current $232.40